Prosecution Insights
Last updated: April 19, 2026

Selecta Biosciences Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18343340 VIRAL VECTOR DOSING PROTOCOLS MOORE, JOHN DAVID 1638 Non-Final OA Jun 28, 2023
17092148 FORMULATIONS AND DOSES OF PEGYLATED URICASE CURRENS, GRANT CARSON 1651 Final Rejection Nov 06, 2020
14296204 REPEATED ADMINISTRATION OF NON-IMMUNOSUPPRESSIVE ANTIGEN SPECIFIC IMMUNOTHERAPEUTICS HALVORSON, MARK 1646 Non-Final OA Jun 04, 2014

Managing Selecta Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month